Nutriband Reported Cash Reserves Of $6.75M As Of July 31, 2024, Supporting The Ongoing Development And Commercialization Efforts For AVERSA Fentanyl
Nutriband Reported Cash Reserves Of $6.75M As Of July 31, 2024, Supporting The Ongoing Development And Commercialization Efforts For AVERSA Fentanyl
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.